|
VISION STATEMENTThe 2006 Cleveland Clinic Bone Innovation Summit is a unique 2.5-day conference designed to bring together clinicians, scientists and industry leaders in multiple disciplines to explore current and future opportunities for advancing the diagnosis and treatment of bone disease and fractures. A renowned faculty of innovative leaders will lead a multilevel journey through bone disease and therapy, starting with fundamental bone biology, the epidemiology of bone disease, and the role and mechanism of existing and evolving therapeutic options. We will also systematically examine the latest perspectives on bone quality, bone imaging, and fracture risk assessment. Emphasis will be placed on challenges and opportunities manifest in the clinical area of osteoporosis, insufficiency fractures, compromised bone repair, non-healing fractures, metastatic bone disease, Paget's Disease and Osteogenesis Imperfecta. The Summit will examine the process of innovation, the ongoing evolution of clinical options for treatment of bone disease, strategies involving bone tissue engineering using drug therapy, cell-based strategies and evolving implantable biomaterials. We will evaluate clinical technologies and systems that may better enable the assessment of new clinical strategies for bone tissue engineering and optimize their use in patient care. Faculty presentations will provide plenary overviews and provocative updates of each topic area. Participants will have the opportunity to present posters, many of which will be selected for short podium presentations. Each session will close with robust discussion between the attendees and a speaker panel comprised of all presenters. Recognizing the integration of the multidisciplinary skills that are needed to advance development and optimal use of current and future therapy options, the Bone Summit format is designed to honor and catalyze innovation. Thought leaders and innovators from clinical practice, academic medicine, basic science and industry are brought together as equal partners in a spirit of collaboration inspired by a shared commitment to optimizing patient care through innovative development, strategic design, objective evaluation, informed use and ongoing critical assessment of current and future therapeutic options. TARGET AUDIENCE
SUMMIT OBJECTIVES At the completion of this summit the attendee will be able to use and apply a state of the art knowledge base in the following topics:
|